Biopharma digital transformation policy design is the need of the hour: Experts at Global Tech Summit 2023

Dr Srinubabu, CEO & MD, Pulsus Group, along with Dr Dominique Jordan, President International Pharmaceutical Federation, Alka Mukni, Prof TV Narayana, President India Pharmaceutical Association

Image- Dr. Srinubabu, CEO and MD, Pulsus Group, along with Dr Dominique Jordan, President International Pharmaceutical Federation, Alka Mukni, Prof TV Narayana, President India Pharmaceutical Association.
New Delhi: The pharmaceutical industry is buzzing with anticipation for the Global Tech Summit 2023, set to take place in Visakhapatnam from February 16–17. Recently, the Global Tech Summit team, led by Dr. Srinubabu Gedela, CEO of Pulsus Group, held a ground-breaking roadshow and business-to-biopharma digital transformation policy design meetings in Nagpur as part of the 72nd Indian Pharmaceutical Congress.
This historic event brought together 50 influential policymakers, global pharma experts, and other decision-makers to discuss how the Global Tech Summit is becoming a revolutionary platform for the application of cutting-edge technology in drug discovery, regulatory affairs, and making medicine more affordable for all.
During the Round Table Series of Biopharma Digital Transformation Policy Deliberations, participants heard from key figures in the industry about the challenges facing regulators in digital healthcare.
Dr. Dominique Jordan, President of the International Pharmaceutical Federation, highlighted the potential impact of technology in revolutionizing drug discovery. “Digital transformation in the pharmaceutical sector involves implementing various digital technologies to improve the production and provision of healthcare products and services,” .
“Digital transformation can benefit the pharmaceutical industry in a variety of ways, including improved drug development, patient care, and interaction; technology helps to make medicine more affordable and accessible; it reduces carbon footprint; and it improves supply chain transparency.” Dr. Jordan added.
The Global Tech Summit team and experts in attendance also discussed the importance of using digital technologies in drug discovery, such as artificial intelligence and machine learning. Dr. Atul Nasa, the former controlling licensure authority, and current president of the Indian Pharma Graduates Association, said, “AI and ML can help accelerate drug discovery by analyzing large amounts of data and identifying potential drug candidates quickly and efficiently.”
“Regulators must find a balance between encouraging innovation and protecting public health,” said Dr. H.G. Koshia, Commissioner of Food and Drug Control Administration, Government of Gujarat. Dr. Montkumar M. Patel, President of the Pharmacy Council of India, also spoke at the meeting about some of the challenges facing regulators when it comes to digital healthcare.
Abhijit Ghoshi, Assistant Drug Controller at the Medical Device Standards Control Organization, provided his expert opinion on the potential way forward for India. “Digital transformation in the pharmaceutical industry is inevitable, and India should take the lead in developing policies that encourage innovation while protecting public health”.
Dr. T. V. Narayana, President of the Indian Pharmaceutical Association, and Dr. Alka Mukne, Editor in Chief of Pharma Times, both emphasized the importance of pharma industry and academic industry collaboration, stating that combining the financial backing of pharma companies with early-stage drug molecules from academic institutions is a key source of innovation, with many successful assets being developed and commercialized through institutional technology out-licensing.
Dr. Atul Nasa, a former controlling licensure authority and current president of the Indian Pharma Graduates Association, who was also part of the discussion, expressed his support for making the Global Tech Summit 2023 a platform for digital transformation in the pharma industry.
The Global Tech Summit: A Platform for Digital Transformation in the Pharma Industry, at the 72nd Indian Pharmaceutical Congress saw several experts and imminent leaders from industry and academia participation, sharing their knowledge about the importance of Digital Transformation in the Pharma Industry”
  • Dr. Sushruta Koppula, Konkuk University Korea
  • Dr. Sridhar Reddy, Global Pharmacovigilance, Hetero Drug
  •  Mr. Rahul Aravind Lad, Glenmark Pharmaceuticals Ltd
  • Dr. Arti R Thakkar, Amity University
  • Dr. Md Saladuddin, Al-Ameen College of Pharmacy
  • Dr.  A Ramesh, Vishnu Institute of Pharmaceutical Sciences
  • Dr.  Y Padmanabha Reddy, Raghavendra institute of Pharmaceutical Education & Research
  •  Mr. Chakravarthi AVPS, Global Ambassador, World Packaging Organisation
  • Dr. Rajkumar Dhar, CEO, Taizhou, Jinuo Biotechnology Co Ltd, China
  • Mr. Sree Kumar, Systopic laboratories Ltd
  • Dr. Mahesh T. Chhabra, LM College of Pharmacy, Gujrat
  • Dr. Chakravarthi AVPS, Global Ambassador, World Packaging Organisation
  • Dr. Manjari Gharath, International Pharmaceutical Federation
  • Dr. Rao Vadlamudi, Ex-President, Indian Pharmaceutical Association
  • Prof. Mahendra Patel, University of Oxford, UK